151 related articles for article (PubMed ID: 32246351)
1. MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor.
Kawaguchi M; Kato H; Hatano Y; Tomita H; Hara A; Suzui N; Miyazaki T; Furui T; Morishige KI; Matsuo M
Jpn J Radiol; 2020 Aug; 38(8):782-789. PubMed ID: 32246351
[TBL] [Abstract][Full Text] [Related]
2. Are CT and MRI useful tools to distinguish between micropapillary type and typical type of ovarian serous borderline tumors?
Zhang Y; Tan J; Wang J; Ai C; Jin Y; Wang H; Li M; Zhang H; Zhong S
Abdom Radiol (NY); 2021 Jul; 46(7):3354-3364. PubMed ID: 33660041
[TBL] [Abstract][Full Text] [Related]
3. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors.
Moro F; Baima Poma C; Zannoni GF; Vidal Urbinati A; Pasciuto T; Ludovisi M; Moruzzi MC; Carinelli S; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2017 Dec; 50(6):788-799. PubMed ID: 28101917
[TBL] [Abstract][Full Text] [Related]
4. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.
Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056
[TBL] [Abstract][Full Text] [Related]
5. Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.
Ahn G; Folkins AK; McKenney JK; Longacre TA
Am J Surg Pathol; 2016 Sep; 40(9):1165-76. PubMed ID: 27487741
[TBL] [Abstract][Full Text] [Related]
6. BRAF
Turashvili G; Grisham RN; Chiang S; DeLair DF; Park KJ; Soslow RA; Murali R
Histopathology; 2018 Sep; 73(3):438-443. PubMed ID: 29770477
[TBL] [Abstract][Full Text] [Related]
7. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.
Nougaret S; Lakhman Y; Molinari N; Feier D; Scelzo C; Vargas HA; Sosa RE; Hricak H; Soslow RA; Grisham RN; Sala E
AJR Am J Roentgenol; 2018 Apr; 210(4):918-926. PubMed ID: 29489407
[TBL] [Abstract][Full Text] [Related]
8. High Frequency of
Ishibashi T; Nakayama K; Razia S; Ishikawa M; Nakamura K; Yamashita H; Dey P; Iida K; Kurioka H; Nakayama S; Otsuki Y; Ishikawa N; Kyo S
Diagnostics (Basel); 2019 Dec; 10(1):. PubMed ID: 31892193
[TBL] [Abstract][Full Text] [Related]
9. Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumors.
Zhang X; Devins K; Ko EM; Reyes MC; Simpkins F; Drapkin R; Schwartz LE; Yoon JY
Gynecol Oncol; 2021 Jun; 161(3):762-768. PubMed ID: 33773808
[TBL] [Abstract][Full Text] [Related]
10. MRI appearances of ovarian serous borderline tumor: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Boyko OB; Wang SJ; Cai SQ; Wang L
J Magn Reson Imaging; 2014 Jul; 40(1):151-6. PubMed ID: 24923479
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of Seromucinous Borderline Tumor from Serous Borderline Tumor on MR Imaging.
Kurata Y; Kido A; Moribata Y; Kameyama K; Minamiguchi S; Konishi I; Togashi K
Magn Reson Med Sci; 2018 Jul; 17(3):211-217. PubMed ID: 28993546
[TBL] [Abstract][Full Text] [Related]
12. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion.
Prat J; De Nictolis M
Am J Surg Pathol; 2002 Sep; 26(9):1111-28. PubMed ID: 12218568
[TBL] [Abstract][Full Text] [Related]
13. Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes.
Hunter SM; Anglesio MS; Ryland GL; Sharma R; Chiew YE; Rowley SM; Doyle MA; Li J; Gilks CB; Moss P; Allan PE; Stephens AN; Huntsman DG; deFazio A; Bowtell DD; ; Gorringe KL; Campbell IG
Oncotarget; 2015 Nov; 6(35):37663-77. PubMed ID: 26506417
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.
Chui MH; Xing D; Zeppernick F; Wang ZQ; Hannibal CG; Frederiksen K; Kjaer SK; Cope L; Kurman RJ; Shih IM; Wang TL; Vang R
Am J Surg Pathol; 2019 Nov; 43(11):1462-1472. PubMed ID: 31343420
[TBL] [Abstract][Full Text] [Related]
15. Role of magnetic resonance imaging to differentiate between borderline and malignant serous epithelial ovarian tumors.
Akçay A; Peker AA; Oran Z; Toprak H; Toluk Ö; Balsak S; Badur BA; Gültekin MA
Abdom Radiol (NY); 2024 Jan; 49(1):229-236. PubMed ID: 37857912
[TBL] [Abstract][Full Text] [Related]
16. Serous surface papillary borderline ovarian tumors: correlation of sonographic features with clinic pathological findings.
Wang D; Su N; Wang R; Zhang L; Qi Z; Liu Z; Yang J; Leng J; Xiang Y;
Ultrasound Obstet Gynecol; 2024 May; 63(5):691-698. PubMed ID: 37592848
[TBL] [Abstract][Full Text] [Related]
17. Stage II to IV low-grade serous carcinoma of the ovary is associated with a poor prognosis: a clinicopathologic study of 32 patients from a population-based tumor registry.
Ali RH; Kalloger SE; Santos JL; Swenerton KD; Gilks CB
Int J Gynecol Pathol; 2013 Nov; 32(6):529-35. PubMed ID: 24071867
[TBL] [Abstract][Full Text] [Related]
18. KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma.
Tsang YT; Deavers MT; Sun CC; Kwan SY; Kuo E; Malpica A; Mok SC; Gershenson DM; Wong KK
J Pathol; 2013 Dec; 231(4):449-56. PubMed ID: 24549645
[TBL] [Abstract][Full Text] [Related]
19. Apparent diffusion coefficient (ADC) values of serous, endometrioid, and clear cell carcinoma of the ovary: pathological correlation.
Ono T; Kishimoto K; Tajima S; Maeda I; Takagi M; Suzuki N; Mimura H
Acta Radiol; 2020 Jul; 61(7):992-1000. PubMed ID: 31698924
[TBL] [Abstract][Full Text] [Related]
20. Extraovarian cystadenomas: ultrasound and MR findings in 7 cases.
Ghossain MA; Braidy CG; Kanso HN; Farah K; Klein-Tomb L; Trak-Smayra V; Suidan JS; Elhage A; Atallah D; Abboud J
J Comput Assist Tomogr; 2005; 29(1):74-9. PubMed ID: 15665687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
